Abstract
Latar Belakang: Tuberkulosis Resisten Obat masih menjadi global burden disease di dunia, dan malnutrisi dapat membuat tuberkulosis menjadi semakin parah. Pengobatan TB RO cukup kompleks, dan dapat menyebabkan efek samping yang memberatkan.
Tujuan :Penelitian ini bertujuan untuk melihat kecenderungan IMT terhadap efek samping pasien TB RO.
Metode :Studi ini adalah penelitian deskriptif retrospektif, yang mengambil data sekunder pasien TB RO di RS Moewardi tahun 2016-2019 sejumlah 246 orang.
Hasil : Pasien underweight dan normal cenderung mengalami efek samping yang berat (20-22,9%), sedangkan pasien overweight memiliki kecenderungan efek samping berat yang lebih kecil (14,3%). Efek samping yang sering ditemui adalah gangguan gastrointestinal (mual, muntah, dll).
Kesimpulan : IMT mungkin berpengaruh terhadap keparahan efek samping yang dialami pasien TB RO, karena sulitnya kebutuhan nutrisi yang dapat tercukupi.
There is no Figure or data content available for this article
References
[2] Dirjen PPPL Kemenkes RI, “Tuberkulosis Multi-Drug Resistant,” Kementrian Kesehatan Republik Indonesia, 2019. [Online]. Available: https://www.tbindonesia.or.id/page/view/22/tb-mdr. [Accessed: 18-May-2020].
[3] A. Mardhiyyah and N. Carolia, “Multi Drug Resistant Tuberculosis pada Pasien Drop Out dan Tatalaksana OAT Lini Kedua Multi Drug Resistant Tuberculosis in Patients Drop Out and Management of Second Line Anti Tuberculosis,” Majority, vol. 5, no. April, pp. 11–16, 2016.
[4] D. N. Reviono, P. Kusnanto, Vicky Eko, Helena Pakiding, “Multidrug Resistant Tuberculosis (MDR-TB): Tinjauan Epidemiologi dan Faktor Resiko Efek Samping Obat Anti Tuberkulosis,” Maj. Kedokt. Bandung, vol. 46, no. 4, pp. 189–196, 2014.
[5] S. D. A. Asri, “Masalah Tuberkulosis Resisten Obat,” Contin. Med. Educ., vol. 41, no. 4, pp. 247–249, 2014.
[6] Y. F. Yen et al., “Association of body mass index with tuberculosis mortality: A population-based follow-up study,” Med. (United States), vol. 95, no. 1, pp. 1–8, 2016.
[7] D. Santy, P. Siagian, B. Y. M. Sinaga, and P. C. Eyanoer, “Hubungan Indeks Massa Tubuh dengan Waktu Konversi Sputum pada Pasien TB MDR yang Menjalani Pengobatan dengan Panduan Jangka Pendek di RSUP Adam Malik Medan,” J. RESPIROLOGI Indones., vol. 40, no. 4, 2020.
[8] Farida, “Faktor keberhasilan pengobatan Multi Drug Resistance Tuberculosa ( MDR-TB ) di Indonesia?: Tinjauan Sistematik Successful factors in the treatment of Multi Drug Resistance Tuberculosa ( MDR-TB ) In Indonesia?: Systematic Review,” J. Heal. Epidemiol. Commun. Dis., vol. 6, no. 1, pp. 35–41, 2020.
[9] World Health Organization (WHO), “Body Mass Index-BMI,” Euro WHO, 2006. [Online]. Available: https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi. [Accessed: 01-Mar-2021].
[10] Kementrian Kesehatan RI, Petunjuk Teknis Manajemen Terpadu Pengendalian Resistan Obat. 2014.
[11] R. W. A. Lazulfa, B. Wirjatmadi, and M. Adriani, “Tingkat Kecukupan Zat Gizi Makro dan Status Gizi Pasien Tuberkulosis dengan Sputum BTA (+) dan Sputum BTA (-),” Media Gizi Indones., vol. 11, pp. 144–152, 2016.
[12] T. W. Yang et al., “Side effects associated with the treatment of multidrug-resistant tuberculosis at a tuberculosis referral hospital in South Korea,” Med. (United States), vol. 96, no. 28, 2017.
[13] I. Warmelink, N. H. Ten Hacken, T. S. Van Der Werf, and R. Van Altena, “Weight loss during tuberculosis treatment is an important risk factor for drug-induced hepatotoxicity,” Br. J. Nutr., vol. 105, no. 3, pp. 400–408, 2011.
[14] M. N. Phan, E. S. Guy, R. N. Nickson, and C. C. Kao, “Predictors and patterns of weight gain during treatment for tuberculosis in the United States of America,” Int. J. Infect. Dis., vol. 53, pp. 1–5, 2016.
[15] A. Kanabus, “Nutrition & TB - Malnutrition, Under Nutrition , Assessment,” TB Facts?: Information About Tuberculosis, 2019. [Online]. Available: https://tbfacts.org/nutrition-tb/. [Accessed: 03-Mar-2021].
[16] L. J. Podewils et al., “Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients,” Epidemiol. Infect., vol. 139, no. 1, pp. 113–120, 2011.
[17] World Health Organization, Guideline?: Nutritional care and support for patients with tuberculosis. 2013.
How to Cite This
Article Metrics
Download Statistics
Downloads
Other Statistics
Copyright and Permissions
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Publishing your paper with Jurnal Teknologi Kesehatan (Jurtekkes) means that the author or authors retain the copyright in the paper. Jurtekkes granted an exclusive reuse license by the author(s), but the author(s) are able to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by Jurtekkes in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.
Jurtekkes journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially.
Jurtekkes journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:
- BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- SA: If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
Data Availability
visitorstatistic
WEBSITE VISITORS